Loading...
PACIFIC subgroup analysis: pneumonitis in stage III, unresectable NSCLC patients treated with durvalumab vs. placebo after CRT
Vansteenkiste, J Naidoo, J Faivre-Finn, Corinne Ozguroglu, M Villegas, A Daniel, D Murakami, S Hui, R Lee, K Cho, BC
Vansteenkiste, J
Naidoo, J
Faivre-Finn, Corinne
Ozguroglu, M
Villegas, A
Daniel, D
Murakami, S
Hui, R
Lee, K
Cho, BC
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Vansteenkiste J, Naidoo J, Faivre-Finn C, Özgüro?lu M, Villegas A, Daniel D, et al. MA05.02 PACIFIC subgroup analysis: pneumonitis in stage III, unresectable NSCLC patients treated with durvalumab vs. placebo after CRT. J Thorac Oncol. 2018 Oct;13(10):S370-371.